MISCHELL SCHLOSSER: Open Payments
NPI 1972070423 · TOLEDO, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$616 in 33 payments from 12 companies in 2025. Trend: 2023 $414 · 2024 $882 · 2025 $616
Food & beverage: $616
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $112 |
| Novartis Pharmaceuticals Corporation | 5 | $103 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $79 |
| AstraZeneca Pharmaceuticals LP | 4 | $64 |
| Amgen Inc. | 4 | $63 |
| Boston Scientific Corporation | 1 | $44 |
| Novo Nordisk Inc | 2 | $43 |
| Esperion Therapeutics, Inc. | 2 | $37 |
| E.R. Squibb & Sons, L.L.C. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: Kerendia, LEQVIO, LifeVest, REPATHA, LOKELMA, WATCHMAN FLX, Wegovy, NEXLETOL.
Industry payments across OH — which companies pay providers there.
